摘要:
The present invention is directed to a highly sensitive method for direct detection of at least one specific RNA in a sample. The presence of a specific RNA provides a positive indicator of a pathogenic agent, contaminant, and/or normal or abnormal genes in the sample. Applications for which the method of the invention is particularly well suited include point-of-care disease diagnosis, detection of microbial contamination in food and/or water supplies, and pathogen detection in biodefense.
摘要:
A novel 3′-terminus modified nucleic acid and a method of making such product using a synthetic nucleotide template with a defined overhang nucleotide are disclosed. The method allows an efficient incorporation of a single modified nucleotide onto the 3′-terminus of the nucleic acid.
摘要:
The invention concerns a regulable shock-absorption valve system for the dashpot in a motor vehicle. It has two shock-absorption valves. Each valve consists of an electromagnetic bolt that slides back and forth and operates in conjunction with at least one port and of a pressure-sensitive valve for the suction stage and for the compression stage, mutually coaxially accommodated in an essentially cylindrical housing and capable of communicating by way of hydraulic-fluid channels. The pressure-sensitive valves (7 & 8) in accordance with the present invention rest on a simple or complex component (15) with its ends permanently or temporarily secured in a bore that extends through the center of the pole cores (17 & 18) of the electromagnets (11) that actuate the bolts (5 & 6). The advantages of the present invention are direct transmission of the shock-absorption forces and simpler assembly of the system.
摘要:
The invention concerns controls for a semiactive chassis on a motor vehicle that is provided with variable or power-regulated vibration attenuators. The results of various sensor measurements are supplied to a regulator that controls the settings in the vibration attenuators on the sky-hook principle.
摘要:
Bioelectrochemical Systems (BES) for use as Biological Oxygen Demand (BOD) sensors, systems incorporating BES sensors for measuring BOD, and methods of using the sensors and systems for measuring BOD. The disclosed sensors are inexpensive to construct, long-lasting, have a fast response, and a large dynamic range. The invention includes biological oxygen demand (BOD) sensors which incorporate at least three working electrodes, at least one counter electrode, a reservoir for dilution fluid, and a sensor for measuring an electric current or a voltage which flows from the working electrodes to the counter electrode. The BOD sensors will typically also include at least one electrically active microbe disposed in proximity to the working electrode.
摘要:
A battery pack apparatus includes a flexible battery pack with an attachment component for attaching the battery pack to and supporting the battery pack on the arms of goggles or eyeglasses worn by a user, the goggles/eyeglasses supporting an electrical device requiring power from the battery pack. The flexible battery pack counter-balances the weight of at least the electrical device when the goggles/eyeglasses are worn by the user. The battery pack apparatus includes a controller that may be wired or remote and that is operable to control the operation of the battery cells within the battery pack.
摘要:
Inhibitors of AMPA-type glutamate ion channels are useful as biochemical probes for structure-function studies and as drug candidates for a number of neurological disorders and diseases. Disclosed herein is the identification of an RNA inhibitor or aptamer by an in vitro evolution approach and characterization of its mechanism of inhibition on the sites of interaction by equilibrium binding and on the receptor channel-opening rate by a laser-pulse photolysis technique. The aptamer of the invention is a noncompetitive inhibitor of AMPA-type glutamate ion channels, one that selectively inhibits the GluA2Qflip AMPA receptor subunit without any effect on other AMPA receptor subunits or on kainate or NMDA receptors. Furthermore, the aptamer preferentially inhibits the closed-channel state of GluA2Qflip with a KI=1.5 μM or by ˜15-fold over the open-channel state. The potency and selectivity of this aptamer rival those of small molecule inhibitors. Together, these properties make the aptamers of the present invention promising water-soluble, highly potent, GluA2 subunit-selective drugs.
摘要:
A cold plate comprises a cold plate body having a base for thermally engaging a heat-generating device, a plurality of internal channels extending through the cold plate body for the passage of a liquid coolant, a first region between the base and the plurality of internal channels, and a second region between the plurality of internal channels and a top that is generally opposite the base from the plurality of internal channels. The cold plate body is made from a first thermally conductive material. The cold plate also comprises at least one thermally conductive member extending around the plurality of channels from the first region below the plurality of channels to the second region above the plurality of channels. The at least one thermally conductive member has a greater thermal conductivity than the first thermally conductive material to move heat from the first region to the second region.
摘要:
Disclosed are compounds of nucleoside 5′-triphosphates of formula (I), or derivatives thereof, or pharmaceutically acceptable salts of said nucleoside 5′-triphosphates or said derivatives, wherein the Base of formula (I) is Adenine (A), Cytosine (C), Guanine (G), Thymine (T), Uracil (U), modified nucleobase or unnatural nucleobase; R1 is H or OH, R2 is H or OH, X is independently selected from the group consisting of O, S and Se; and Y is independently selected from the group consisting of O, B (borano, or BH3), S, and Se. Also disclosed are processes of preparing the compounds of formula (I), said process comprising steps according to Scheme A:
摘要:
The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.